Product Safety Recalls

Product Recall Tracker

Recall D-0719-2022

Description: NAD+ Nicotinamide Adenine Dinucleotide, Lyophilized powder for reconstitution, Multi-Dose 500 mg per vial, Each ML contains: 0.288% Sodium Phosphate Monobasic USP, 0.42% Sodium Phosphate Dibasic USP, 5% Mannitol USP, Sterile Water for Injection USP, Rx Only, Olympia Pharmaceuticals 6700 Conroy Rd., Ste. 155, Orlando, FL 32835 NDC: 73198-0083-00

Recall D-0719-2022 Information

StatusOngoing
Mandated?Voluntary: Firm initiated
Recall NumberD-0719-2022
Event ID89717
DistributionNationwide in the USA including Puerto Rico.
Quantity2634 vials
Recall ReasonProduct found to be Sub Potent or Exceeded reconstitution time
Drug ClassificationClass II
Drug Code Info20220330
Recall Initiation Date20220308
Report Date20220330
Classification Date20220329
Address6700 Conroy Rd Ste 155
Orlando, FL 32835-3515
United States
Recalling FirmOlympia Compounding Pharmacy dba Olympia Pharmacy
Initial Notification Letter
Similar To

© 2021 Recall.Report / Contact / Privacy Policy

This site's data is aggregated programmatically and provided "as is" without any representations or warranties, express or implied.
Recall.report is not affiliated with the Consumer Product Safety Commision, FDA, or US government in any way.